Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Hirschmann

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Arzneimittel-Forschung|January 1, 1976
[Clinical problems of optimum bioavailability, in particular in cytostatic therapy (author's transl)]R Gross, W D Hirschmann
Pneumologie (Stuttgart, Germany)|June 1, 1990
[Ciprofloxacin in the treatment of Legionnaires' disease]L Zabel, W D Hirschmann
Klinische Wochenschrift|October 3, 1983
Long term follow-up of remission patients in adult acute leukemiaD Gerecke, M Kress, W D Hirschmann
The Clinical Investigator|November 1, 1992
Left main coronary stenosis by a mediastinal lymphomaU Zeymer, W D Hirschmann, K L Neuhaus
Deutsche Medizinische Wochenschrift (1946)|September 1, 1989
[T-cell lymphoma associated with sprue]W Ormann, W D Hirschmann, E Alexandrakis, et al.
Blut|July 1, 1979
Remission induction and remission maintenance in adult acute nonlymphocytic leukemia employing a modified cytostatic (COAP) regimenD Gerecke, W D Hirschmann, R Voigtmann, et al.
Acta Haematologica|November 28, 2006
Aplastic crisis as a complication of congenital dyserythropoietic anemia type IIH Heimpel, H Wilts, W D Hirschmann, et al.
Klinische Wochenschrift|July 15, 1987
[Beta interferon therapy in hairy cell leukemia]P von Wussow, J Dühlmann, T Grethlein, et al.
Seminars in Oncology|April 1, 1992
Fluorouracil versus folinic acid/fluorouracil in advanced colorectal cancer--preliminary results of a randomized trialB Steinke, E Günther, W D Hirschmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trialE Heidemann, H Stoeger, R Souchon, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Arzneimittel-Forschung|January 1, 1976
[Clinical problems of optimum bioavailability, in particular in cytostatic therapy (author's transl)]R Gross, W D Hirschmann
Pneumologie (Stuttgart, Germany)|June 1, 1990
[Ciprofloxacin in the treatment of Legionnaires' disease]L Zabel, W D Hirschmann
Klinische Wochenschrift|October 3, 1983
Long term follow-up of remission patients in adult acute leukemiaD Gerecke, M Kress, W D Hirschmann
The Clinical Investigator|November 1, 1992
Left main coronary stenosis by a mediastinal lymphomaU Zeymer, W D Hirschmann, K L Neuhaus
Deutsche Medizinische Wochenschrift (1946)|September 1, 1989
[T-cell lymphoma associated with sprue]W Ormann, W D Hirschmann, E Alexandrakis, et al.
Blut|July 1, 1979
Remission induction and remission maintenance in adult acute nonlymphocytic leukemia employing a modified cytostatic (COAP) regimenD Gerecke, W D Hirschmann, R Voigtmann, et al.
Acta Haematologica|November 28, 2006
Aplastic crisis as a complication of congenital dyserythropoietic anemia type IIH Heimpel, H Wilts, W D Hirschmann, et al.
Klinische Wochenschrift|July 15, 1987
[Beta interferon therapy in hairy cell leukemia]P von Wussow, J Dühlmann, T Grethlein, et al.
Seminars in Oncology|April 1, 1992
Fluorouracil versus folinic acid/fluorouracil in advanced colorectal cancer--preliminary results of a randomized trialB Steinke, E Günther, W D Hirschmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trialE Heidemann, H Stoeger, R Souchon, et al.
Pageof 2